drugset
drugset / Trial / NCT03219801

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus

NCT03219801 ↗

Phase 0 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the safety and efficacy of human umbilical cord derived mesenchymal stem cells transplantation in systemic lupus erythematosus.

Timeline

Start
2017-08-01
Primary completion
2018-12-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Umbilical Cord-derived Mesenchymal Stem Cells Cell therapy — Intravenous

Indications

systemic lupus erythematosus